Abstract A077: Integrated biomarker analysis of circulating tumor cells, circulating tumor DNA and extracellular vesicles in a single blood draw: Longitudinal monitoring for pancreatic cancer
The high fatality of pancreatic cancer is primarily attributed to late-stage diagnosis and high recurrence rates. Among patients eligible for resection surgery, recurrence rates reach approximately 70% with a median survival of 27.9 months, highlighting the urgent need to longitudinally monitor these patients and...